Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Iankov

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapyIanko D Iankov, Boris Blechacz, Chunsheng Liu, et al.
The Prostate|November 1, 2008
Engineered measles virus as a novel oncolytic therapy against prostate cancerPavlos Msaouel, Ianko D Iankov, Cory Allen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virusIanko D Iankov, Cory Allen, Mark J Federspiel, et al.
Expert Opinion on Biological Therapy|January 16, 2008
Oncolytic measles virus strains in the treatment of gliomasCory Allen, Georgia Paraskevakou, Chunsheng Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2009
Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporterPavlos Msaouel, Ianko D Iankov, Cory Allen, et al.
The Journal of Clinical Investigation|July 1, 2021
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapyEleni Panagioti, Cheyne Kurokawa, Kimberly Viker, et al.
Breast Cancer Research and Treatment|November 7, 2009
Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer modelIanko D Iankov, Pavlos Msaouel, Cory Allen, et al.
Cancer Gene Therapy|August 15, 2015
Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapyI D Iankov, C B Kurokawa, A B D'Assoro, et al.
Molecular Therapy. Oncology|November 14, 2025
Oncolytic measles virotherapy encoding the neutrophil-activating protein is effective in synovial sarcomaSteven I Robinson, Susan M Clark, Ianko D Iankov, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapyIanko D Iankov, Boris Blechacz, Chunsheng Liu, et al.
The Prostate|November 1, 2008
Engineered measles virus as a novel oncolytic therapy against prostate cancerPavlos Msaouel, Ianko D Iankov, Cory Allen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virusIanko D Iankov, Cory Allen, Mark J Federspiel, et al.
Expert Opinion on Biological Therapy|January 16, 2008
Oncolytic measles virus strains in the treatment of gliomasCory Allen, Georgia Paraskevakou, Chunsheng Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2009
Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporterPavlos Msaouel, Ianko D Iankov, Cory Allen, et al.
The Journal of Clinical Investigation|July 1, 2021
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapyEleni Panagioti, Cheyne Kurokawa, Kimberly Viker, et al.
Breast Cancer Research and Treatment|November 7, 2009
Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer modelIanko D Iankov, Pavlos Msaouel, Cory Allen, et al.
Cancer Gene Therapy|August 15, 2015
Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapyI D Iankov, C B Kurokawa, A B D'Assoro, et al.
Molecular Therapy. Oncology|November 14, 2025
Oncolytic measles virotherapy encoding the neutrophil-activating protein is effective in synovial sarcomaSteven I Robinson, Susan M Clark, Ianko D Iankov, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Pageof 5